1. Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, et al. Emerging concepts in sporadic cerebral amyloid angiopathy.
Brain 2017;140:1829-1850.
2. Farid K, Charidimou A, Baron JC. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: a systematic critical update.
Neuroimage Clin 2017;15:247-263.
3. Charidimou A, Farid K, Tsai HH, Tsai LK, Yen RF, Baron JC. Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance.
J Neurol Neurosurg Psychiatry 2018;89:410-417.
5. Roberts RO, Aakre JA, Kremers WK, Vassilaki M, Knopman DS, Mielke MM, et al. Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting.
JAMA Neurol 2018;75:970-979.
6. Charidimou A, Farid K, Baron JC. Amyloid-PET in sporadic cerebral amyloid angiopathy: a diagnostic accuracy meta-analysis.
Neurology 2017;89:1490-1498.
8. van Veluw SJ, Arfanakis K, Schneider JA. Neuropathology of vascular brain health: insights from ex vivo magnetic resonance imaging-histopathology studies in cerebral small vessel disease.
Stroke 2022;53:404-415.
9. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.
Ann Neurol 2007;62:229-234.
10. Chang Y, Liu J, Wang L, Li X, Wang Z, Lin M, et al. Diagnostic utility of integrated 11C-Pittsburgh compound B positron emission tomography/magnetic resonance for cerebral amyloid angiopathy: a pilot study.
Front Aging Neurosci 2021;13:721780.
11. Jang H, Jang YK, Kim HJ, Werring DJ, Lee JS, Choe YS, et al. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Eur J Nucl Med Mol Imaging 2019;46:1287-1298.
13. Chapleau M, Iaccarino L, Soleimani-Meigooni D, Rabinovici GD. The role of amyloid PET in imaging neurodegenerative disorders: a review.
J Nucl Med 2022;63(Suppl 1):13S-19S.
14. Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease.
Ann Neurol 2016;79:110-119.
15. Medeiros R, Baglietto-Vargas D, LaFerla FM. The role of tau in Alzheimer’s disease and related disorders.
CNS Neurosci Ther 2011;17:514-524.
16. Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Schöll M, Strandberg O, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders.
JAMA 2018;320:1151-1162.
17. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy.
Neurology 2010;74:1346-1350.
18. Charidimou A, Boulouis G, Frosch MP, Baron JC, Pasi M, Albucher JF, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
Lancet Neurol 2022;21:714-725.
19. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimers Dement 2011;7:263-269.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia.
Br J Psychiatry 1982;140:566-572.
22. Tsai HH, Chen YF, Yen RF, Lo YL, Yang KC, Jeng JS, et al. Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
Brain 2021;144:3371-3380.
23. Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw FE, et al. Neuroimaging standards for research into small vessel disease-advances since 2013.
Lancet Neurol 2023;22:602-618.
24. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation.
Lancet Neurol 2009;8:165-174.
25. Charidimou A, Boulouis G, Roongpiboonsopit D, Auriel E, Pasi M, Haley K, et al. Cortical superficial siderosis multifocality in cerebral amyloid angiopathy: a prospective study.
Neurology 2017;89:2128-2135.
26. Tsai HH, Pasi M, Tsai LK, Huang CC, Chen YF, Lee BC, et al. Centrum semiovale perivascular space and amyloid deposition in spontaneous intracerebral hemorrhage.
Stroke 2021;52:2356-2362.
27. Charidimou A, Boulouis G, Pasi M, Auriel E, van Etten ES, Haley K, et al. MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy.
Neurology 2017;88:1157-1164.
28. Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer’s disease.
J Nucl Med 2007;48:547-552.
29. Pasi M, Pongpitakmetha T, Charidimou A, Singh SD, Tsai HH, Xiong L, et al. Cerebellar microbleed distribution patterns and cerebral amyloid angiopathy.
Stroke 2019;50:1727-1733.
30. Tsai HH, Pasi M, Tsai LK, Chen YF, Chen YW, Tang SC, et al. Superficial cerebellar microbleeds and cerebral amyloid angiopathy: a magnetic resonance imaging/positron emission tomography study.
Stroke 2020;51:202-208.
32. Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, et al. Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment.
JAMA Neurol 2022;79:975-985.
33. Groot C, Villeneuve S, Smith R, Hansson O, Ossenkoppele R. Tau PET imaging in neurodegenerative disorders.
J Nucl Med 2022;63(Suppl 1):20S-26S.
34. Switzer AR, Charidimou A, McCarter S, Vemuri P, Nguyen AT, Przybelski SA, et al. Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: an MRI-neuropathologic validation study.
Neurology 2024;102:e209386.
37. McCarter SJ, Lesnick TG, Lowe V, Mielke MM, Constantopoulos E, Rabinstein AA, et al. Cerebral amyloid angiopathy pathology and its association with amyloid-β PET signal.
Neurology 2021;97:e1799-e1808.
38. Greenberg SM, Grabowski T, Gurol ME, Skehan ME, Nandigam RN, Becker JA, et al. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.
Ann Neurol 2008;64:587-591.
40. Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, et al. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer’s subjects.
Neuroimage Clin 2015;9:592-598.
41. Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O’Keefe G, et al. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease.
Eur J Nucl Med Mol Imaging 2012;39:983-989.
42. Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, et al. PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis.
Brain 2007;130(Pt 10):2607-2615.
43. Abrahamson EE, Stehouwer JS, Vazquez AL, Huang GF, Mason NS, Lopresti BJ, et al. Development of a PET radioligand selective for cerebral amyloid angiopathy.
Nucl Med Biol 2021;92:85-96.
44. Zha Z, Song J, Choi SR, Wu Z, Ploessl K, Smith M, et al. (68) Ga-bivalent polypegylated styrylpyridine conjugates for imaging Aβ plaques in cerebral amyloid angiopathy.
Bioconjug Chem 2016;27:1314-1323.
45. Zhang Q, Zhao X, Lei P, Kung HF, Yang Z, Zhu L, et al. Evaluating [68Ga]Ga-p14-032 as a novel PET tracer for diagnosis cerebral amyloid angiopathy.
Front Neurol 2021;12:702185.
46. Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, et al. Existing Pittsburgh compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Brain 2015;138(Pt 7):2020-2033.
47. Schoemaker D, Charidimou A, Zanon Zotin MC, Raposo N, Johnson KA, Sanchez JS, et al. Association of memory impairment with concomitant tau pathology in patients with cerebral amyloid angiopathy.
Neurology 2021;96:e1975-e1986.
48. Ly JV, Donnan GA, Villemagne VL, Zavala JA, Ma H, O’Keefe G, et al. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage.
Neurology 2010;74:487-493.